| Product Code: ETC088664 | Publication Date: Jun 2021 | Updated Date: Sep 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The radiopharmaceuticals market in Thailand was valued at US$ 20 million in 2025 and is anticipated to grow reaching US$ 27 million with compound annual growth rate (CAGR) of 5.7%. The presence of well-developed healthcare infrastructure along with better support from government authorities has enabled quick accessibility among citizens for advanced medical treatments including diagnostic imaging procedures utilizing radioisotopes have been fueling up sales opportunities across this domain on account of its wide range applications spanning across Oncology diagnostics & therapeutics followed closely behind other therapeutic domains like Cardiology & Neurology respectively amongst others
The radiopharmaceutical market in Thailand is driven by advancements in medical imaging and diagnostic technologies. Radiopharmaceuticals are essential for nuclear medicine procedures, enabling accurate disease diagnosis and treatment monitoring. The increasing prevalence of chronic diseases and the demand for non-invasive diagnostic methods support the growth of this market.
In the radiopharmaceutical market, challenges include regulatory compliance and logistics. Radiopharmaceuticals are subject to strict regulations due to their radioactive nature. Ensuring proper licensing, handling, transportation, and disposal of radioactive materials are critical challenges to address in this market.
The radiopharmaceutical market faced disruptions as healthcare systems focused on managing the pandemic. Diagnostic procedures and non-essential medical activities were deferred, affecting the demand for radiopharmaceuticals used in medical imaging.
The radiop harmaceutical market involves companies like Thai Radiopharmaceuticals Co., Ltd. and Advanced Research Imaging Center (ARIC). These players offer radiopharmaceutical products used in medical imaging and nuclear medicine procedures.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Radiopharmaceutical Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Radiopharmaceutical Market - Industry Life Cycle |
3.4 Thailand Radiopharmaceutical Market - Porter's Five Forces |
3.5 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.8 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Thailand Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Thailand Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in prevalence of cancer and cardiovascular diseases in Thailand |
4.2.2 Growing awareness about the benefits of nuclear medicine and radiopharmaceuticals |
4.2.3 Technological advancements in radiopharmaceutical production and imaging techniques |
4.3 Market Restraints |
4.3.1 High costs associated with radiopharmaceutical production and procurement |
4.3.2 Lack of skilled professionals in the field of nuclear medicine |
4.3.3 Stringent regulatory requirements for radiopharmaceutical manufacturing and distribution |
5 Thailand Radiopharmaceutical Market Trends |
6 Thailand Radiopharmaceutical Market, By Types |
6.1 Thailand Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Types, 2021-2031F |
6.1.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.4 Thailand Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.2 Thailand Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.2.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2021-2031F |
6.3 Thailand Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
6.4 Thailand Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2021-2031F |
6.4.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2021-2031F |
6.5 Thailand Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.5.4 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2021-2031F |
6.5.5 Thailand Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2021-2031F |
6.5.6 Thailand Radiopharmaceutical Market Revenues & Volume, By Others, 2021-2031F |
7 Thailand Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Thailand Radiopharmaceutical Market Export to Major Countries |
7.2 Thailand Radiopharmaceutical Market Imports from Major Countries |
8 Thailand Radiopharmaceutical Market Key Performance Indicators |
8.1 Number of new radiopharmaceutical products introduced in the market |
8.2 Investment in research and development of new radiopharmaceuticals |
8.3 Adoption rate of nuclear medicine and radiopharmaceutical imaging techniques in healthcare facilities |
9 Thailand Radiopharmaceutical Market - Opportunity Assessment |
9.1 Thailand Radiopharmaceutical Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Thailand Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Thailand Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
9.4 Thailand Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Thailand Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Thailand Radiopharmaceutical Market - Competitive Landscape |
10.1 Thailand Radiopharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Thailand Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |